CHEBI:63457 - fibroblast growth factor receptor antagonist

Main

ChEBI Ontology

Automatic Xrefs

Reactions

Pathways

Models

ChEBI Name fibroblast growth factor receptor antagonist ChEBI ID CHEBI:63457 Definition An antagonist at the fibroblast growth factor receptor. Stars This entity has been manually annotated by the ChEBI Team. ChEBI Ontology Outgoing fibroblast growth factor receptor antagonist (CHEBI:63457) is a antagonist (CHEBI:48706) Incoming 2-amino-5-[(1-methoxy-2-methylindolizin-3-yl)carbonyl]benzoic acid (CHEBI:73307) has role fibroblast growth factor receptor antagonist (CHEBI:63457) AZD4547 (CHEBI:63453) has role fibroblast growth factor receptor antagonist (CHEBI:63457) BGJ-398 (CHEBI:63451) has role fibroblast growth factor receptor antagonist (CHEBI:63457) brivanib (CHEBI:167686) has role fibroblast growth factor receptor antagonist (CHEBI:63457) brivanib alaninate (CHEBI:167656) has role fibroblast growth factor receptor antagonist (CHEBI:63457) E-3810 (CHEBI:65138) has role fibroblast growth factor receptor antagonist (CHEBI:63457) E-3810 free base (CHEBI:65209) has role fibroblast growth factor receptor antagonist (CHEBI:63457) lenvatinib (CHEBI:85994) has role fibroblast growth factor receptor antagonist (CHEBI:63457) lenvatinib mesylate (CHEBI:85995) has role fibroblast growth factor receptor antagonist (CHEBI:63457) nintedanib (CHEBI:85164) has role fibroblast growth factor receptor antagonist (CHEBI:63457) nintedanib esylate (CHEBI:85170) has role fibroblast growth factor receptor antagonist (CHEBI:63457) PD173074 (CHEBI:63448) has role fibroblast growth factor receptor antagonist (CHEBI:63457) sodium 2-amino-5-[(1-methoxy-2-methylindolizin-3-yl)carbonyl]benzoate (CHEBI:73280) has role fibroblast growth factor receptor antagonist (CHEBI:63457) SU5402 (CHEBI:63449) has role fibroblast growth factor receptor antagonist (CHEBI:63457) Synonyms Sources FGFR inhibitor ChEBI FGFR inhibitors ChEBI fibroblast growth factor receptor antagonists ChEBI fibroblast growth factor receptor inhibitor ChEBI fibroblast growth factor receptor inhibitors ChEBI Last Modified 16 March 2021